Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

BUY
$8.54 - $20.22 $697,376 - $1.65 Million
81,660 Added 44.8%
263,940 $5.03 Million
Q3 2023

Nov 13, 2023

BUY
$10.13 - $13.98 $1.85 Million - $2.55 Million
182,280 New
182,280 $2.09 Million

Others Institutions Holding ALPN

About ALPINE IMMUNE SCIENCES, INC.


  • Ticker ALPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 44,006,700
  • Description
  • Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28...
More about ALPN
Track This Portfolio

Track Nan Fung Group Holdings LTD Portfolio

Follow Nan Fung Group Holdings LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nan Fung Group Holdings LTD, based on Form 13F filings with the SEC.

News

Stay updated on Nan Fung Group Holdings LTD with notifications on news.